| Trial ID: | L2247 |
| Source ID: | NCT01957930
|
| Associated Drug: |
Intensified Insulin Treatment
|
| Title: |
Intensive Insulin Treatment and Ischemic Foot Ulcer
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01957930/results
|
| Conditions: |
Ischemic Foot Ulcer
|
| Interventions: |
DRUG: Intensified insulin treatment|DRUG: Standard treatment
|
| Outcome Measures: |
Primary: Ischemic Foot Ulcer, The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code, Until hospitalization for ischemic foot ulcer or until 31 December 2011 | Other: Microvascular Endothelial Function, Microvascular function is measured with a single point iontophoresis after stimulation with topically applied acetylcholine (ACh) \[endothelial-dependent\], sodium nitroprusside (SNP) \[endothelial-independent\], and capsaicin \[C-nociceptive dependent\] vasculature response., 7 years
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
91
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
1984-01
|
| Completion Date: |
2013-06
|
| Results First Posted: |
2015-12-21
|
| Last Update Posted: |
2020-09-29
|
| Locations: |
Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, 118 83, Sweden|Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB, Stockholm, 118 83, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01957930
|
